AlphaMark Advisors’s Foundation Medicine, Inc. FMI Stock Holding History

AlphaMark Advisors’s Portfolio FMI Stock Details FMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-38,981	Closed	-$690K	–	526
2016 Q4	$690K	Hold	38,981	–	–	0.36%	63
2016 Q3	$910K	Sell	38,981 -9,000	-19%	-$204K	0.46%	51
2016 Q2	$895K	Hold	47,981	–	–	0.53%	49
2016 Q1	$872K	Sell	47,981 -15,267	-24%	-$246K	0.46%	50
2015 Q4	$1.33M	Buy	+63,248	New	+$1.22M	0.68%	43

Other funds holding FMI

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGI

Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

AlphaMark Advisors's FMI Position: Q1 2017 in Review

AlphaMark Advisors sold out of Foundation Medicine, Inc. (FMI) in Q1 2017, closing a stake of 38,981 shares — an estimated $690K sold.

AlphaMark Advisors first reported a position in FMI in Q4 2015 and held it in 5 quarters. The position peaked at $1.33M in Q4 2015. 93 funds tracked by Wall St. Rank hold FMI as of Q1 2017.

AlphaMark Advisors reported no remaining Foundation Medicine, Inc. position as of Q1 2017 after selling out during the quarter.
AlphaMark Advisors sold 38,981 Foundation Medicine, Inc. shares in Q1 2017, an estimated $690K.
AlphaMark Advisors first reported a position in Foundation Medicine, Inc. in Q4 2015 and held it in 5 quarters.
AlphaMark Advisors's Foundation Medicine, Inc. position peaked at $1.33M in Q4 2015.
93 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q1 2017.

Based on AlphaMark Advisors's 13F filing for Q1 2017, filed 9 May 2017.